OncoDaily

81.3K posts

OncoDaily banner
OncoDaily

OncoDaily

@oncodaily

Your daily dose of hope, inspiration, and information in the fight against cancer. OncoDaily - The Voice of Oncology

Boston, MA Katılım Mayıs 2023
7.5K Takip Edilen8.8K Takipçiler
Drew Moghanaki
Drew Moghanaki@DrewMoghanaki·
Post SBRT image evaluation ambiguities are real and certainly an issue. It theoretically might undermines a patient’s outcome if mismanaged (unnecessary biopsies, etc). Although the theoretical harms associated with that maybe similar in frequency to postop complication rates after nephrectomy. Which is why I think we really need a RCT to confirm the benefit of surgery at this time in history to feel better about endorsing an operation. @_ShankarSiva
Tobias Büttner@tobiasmbuettner

@DrewMoghanaki SBRT is excellent for inoperable RCC! But for operable pts, the bar is high: Robotic partial nephrectomy offers good safety & low toxicity. Plus, SBRT competes with surgery + full histology + adjuvant therapy options. And yet, no biomarker = tricky post-SBRT imaging?

English
5
6
13
4.9K
OncoDaily
OncoDaily@oncodaily·
⏳ Last Chance to Register for This AI Session at #ASCO2026 The future of oncology is being shaped by artificial intelligence — and this conversation brings together some of the leading voices driving that change. 🎙 Douglas Flora • Pavan Anné • Cristian Massacesi • Debra Patt • Sanjay Juneja • Sunil Verma 📅 May 30, 2026 🕒 5:00 – 8:00 PM 📍 Hyatt Regency McCormick Place, Chicago 🤝 @ZSAssociates, a global consulting and technology firm is serving as exclusive co-host of the event. 🔗Read more: oncodaily.com/grand-rounds-a… 🔗Register here: forms.gle/E6YM21AYp3WS4U… @db_pavan @dougflora2 @dapattmd @therealoncdoc @cancermd
OncoDaily tweet media
English
0
0
0
42
OncoDaily
OncoDaily@oncodaily·
⏳ Last Call: OncoDaily Grand Rounds at ASCO — Sarcoma Edition Co-chaired by Dr. @sandrapdangelo & Dr. @herbloong Featuring Dr. Javier Martín-Broto & Dr. @RobinL_Jones Jones 📅 Friday, May 29, 2026 🕒 3:30 – 5:30 pm (Chicago Time) 📍 Hilton Chicago 🤝Foundational partner: @EliLillyandCo 🥉 Bronze Sponsor: @USWorldMeds 🍽 Connect with peers over food and drinks 🔗Read more: oncodaily.com/grand-rounds-a… 🔗Register now: lnkd.in/dhGDPcQd
OncoDaily tweet media
English
0
0
1
35
Enrique Grande
Enrique Grande@drenriquegrande·
⚡️ IMvigor011 at #ASCO26: ctDNA-guided adjuvant atezolizumab in MIBC improved DFS and OS in ctDNA+ patients — with no negative impact on patient-reported QoL. >90% of patients reported little or no treatment side-effect burden throughout therapy. Efficacy and tolerability together. Relevant for shared decision-making in the adjuvant setting. #BladderCancer @OncoBellmunt @ASCO asco.org/abstracts-pres…
Enrique Grande tweet media
English
1
11
22
933
Tedros Adhanom Ghebreyesus
am thrilled to sign the African Medicine Agency @AUAMA -@WHO Framework Agreement for Collaboration alongside my sister, Delese Mimi Darko. Together, we will work to enhance access to quality medicines throughout Africa, reinforcing our commitment to #HealthForAll. Continental institutions play a vital and complementary role alongside global organizations, and WHO will continue to provide both financial and technical support.
Tedros Adhanom Ghebreyesus tweet mediaTedros Adhanom Ghebreyesus tweet mediaTedros Adhanom Ghebreyesus tweet mediaTedros Adhanom Ghebreyesus tweet media
English
19
40
109
8K
OncoDaily retweetledi
OncoDaily GI
OncoDaily GI@OncoDailyGI·
10 Must-Read Posts in GI Oncology | Third Week of May This week’s GI oncology highlights cover: • ctDNA in locally advanced pMMR colon cancer • Perioperative gastro-oesophageal adenocarcinoma care • Single-cell pancreatic cancer models • Tailored mesorectal excision in rectal cancer • ASCO ctDNA presentations, including GALAXY • CheckMate 649 5-year follow-up • CRC management in older adults • Low-risk pancreatic cyst surveillance • Tolerability in advanced GI malignancies • uPA-responsive photoacoustic imaging in CRC models @DrHongchengZhu @FLordick28391 @KoheiShitara @LizzySmyth1 @NelsonDusetti @RMirnezami @OncoJurdi @ArndtVogel @3isac @MichelDucreux @ilyassahinMD @TimothyJBrownMD @SinharaySanhita oncodaily.com/oncolibrary/ga… #GIOncology #OncoDaily
OncoDaily GI tweet media
English
0
5
9
221
OncoDaily retweetledi
OncoDaily GU
OncoDaily GU@OncoDailyGU·
10 Must-Read Posts in GU Oncology | Third Week of May This week’s GU oncology highlights cover: • Prostate radiotherapy automation • IMmotion150 in metastatic ccRCC • Salvage RT after prostatectomy • PSMAddition and Pluvicto • Olaparib in BRCA-mutated mCRPC • CheckMate 274 5-year update • ASCO26 oncology preview, including POTOMAC • ctDNA + utDNA in bladder-sparing MIBC • HPV evaluation in penile cancer • EV-303 / KEYNOTE-905 in cisplatin-ineligible MIBC @drenriquegrande @josedsh @amerseburger @LuigiFormisano_ @nancyghattas 📎oncodaily.com/genitourinary-… #GUOncology #OncoDaily
OncoDaily GU tweet media
English
0
4
8
184